"Federal drug R&D ill-conceived"
Vertex thriving with own resources
By Jonathan (Josh) Bloom, Ph.D.
Publish Date : Tuesday, November 1, 2011
The Boston Herald ACSH’s Dr. Josh Bloom argues that the government's recent decision to take up drug discovery will in all likelihood be a futile — and expensive — effort. He contrasts the government’s inexpert endeavor with the impressive successes of the pharmaceutical start-up Vertex, a much better example of how to go about developing important new drugs.  Read Full >>

"For the Democracy of Science"
By Alyssa Pelish
Publish Date : Friday, October 28, 2011
Science Magazine ACSH's Director of Publications Alyssa Pelish reviews Shawn Lawrence Otto’s Fool Me Twice: Fighting the Assault on Science in America. Otto's book considers how the voting public can, in fact, take up arms against politicians who would sway their constituents with sheerly rhetorical claims about public policy decisions that should be based instead on the relevant science.  Read Full >>

Running Out of Common Drugs (NY Post)
By Jonathan (Josh) Bloom, Ph.D.
Publish Date : Tuesday, August 16, 2011
By Dr. Josh Bloom. People are dying because of critical shortages of hundreds of essential, commonly used drugs — the kind we take for granted.  Read Full >>

The CDC vs. Life-Saving Vaccines (National Review)
By Jonathan (Josh) Bloom, Ph.D.
Publish Date : Thursday, July 21, 2011
Is the federal agency cutting costs by refusing to approve vaccines for children?  Read Full >>

Warnings that Don't Work (National Review Online)
By Elizabeth M. Whelan, Sc.D., M.P.H.
Publish Date : Tuesday, July 5, 2011
By Dr. Elizabeth M. Whelan Diseased lungs. Corpses. Rotting teeth. A man smoking from a tracheotomy hole. These are some of the shocking images featured in the Food and Drug Administration’s recently unveiled series of cigarette package warnings. The FDA asserts that these graphic warnings will serve public health by terrifying smokers into quitting. Commissioner Margaret Hamburg boasts that “the FDA [is taking] a crucial step toward reducing the   Read Full >>

Junk Science Week: Toxic terrorists ignore organic food threat (Financial Post)
By Gilbert Ross, M.D.
Publish Date : Wednesday, June 15, 2011
By Gilbert Ross. A respected newspaper notes the latest toll among Europeans of a virulent strain of the bacterium E. coli, the source of which has recently been determined to be sprouts from an organic farm in Germany. In the same newspaper, a few pages distant, a credulous journalist has in essence copied and pasted another press release from the Environmental Working Group (EWG), a U.S. activist organization, warning us yet again about the traces of pesticide residues on their   Read Full >>

Statement of The American Council on Science and Health on Plain Packaging legislation in Australia
Publish Date : Friday, June 3, 2011
The American Council on Science and Health (ACSH) has been in the forefront of anti-smoking education for the consumer since our founding in 1978.  Read Full >>

Dr. Gilbert Ross on the Dr. Joe Show
By Gilbert Ross, M.D.
Publish Date : Thursday, May 19, 2011
Listen to ACSH's Dr. Gilbert Ross talk chemophobia, radiation scares, and the promotion of sound science with beloved chemistry professor and radio show host Dr. Joe Schwarcz on The Dr. Joe Show.  Read Full >>

Better Living Through Chemistry (The American)
By Gilbert Ross, M.D.
Publish Date : Thursday, May 5, 2011
The overwhelming body of scientific evidence supports the safety of myriad chemicals in use today.A fusillade of recent items by the New York Times, US News, CNN, and others purports to show how certain common pesticides lead to reduced IQs among children of women exposed to these chemicals while pregnant.  Read Full >>

The Real Reason Drug Companies are Failing? (Medical Progress Today)
The FDA has gotten tougher, but that's not the only problem
By Jonathan (Josh) Bloom, Ph.D.
Publish Date : Friday, April 15, 2011
Trouble in the pharmaceutical industry has become so evident that major news organizations are belatedly taking note of it. This was evidenced by a recent plethora of stories about the slew of looming patent expirations major drug companies are facing. Some important reasons have been examined, but there is much more to the story.  Read Full >>